Eirgen Pharma

End-to-end oral solid dose drug development services for global markets

General Information
Company Name
Eirgen Pharma
Founded Year
2005
Location (Offices)
Ireland +1
Founders / Decision Makers
Number of Employees
148
Industries
Health Care, Manufacturing, Pharmaceutical
Funding Stage
-
Social Media

Eirgen Pharma - Company Profile

Eirgen Pharma is a research-driven company specializing in the development, manufacture, and supply of a broad range of High Potency Oral Solid Dose (OSD) Human & Veterinary specialty products. Since 2006, the company has been a pioneer in developing and manufacturing film-coated tablets, soft-gel capsules, and powder or liquid-filled hard-shell capsules, with a focus on successfully producing cancer chemotherapy drugs. This success has established strong partnerships with leading pharmaceutical companies, leading to the acquisition of Eirgen Pharma by the OPKO Health family of companies in 2015. The acquisition has empowered Eirgen Pharma to invest further in facilities and people, expanding their development and manufacturing capabilities. Currently, Eirgen Pharma serves patients in more than 60 countries worldwide, including major markets like the USA, Europe, Japan, Canada, Australia, the Middle East, and Africa. The company's centre of excellence in Waterford, Ireland, provides full turnkey CDMO services for the development, manufacture, and packaging of high potency oral dose medicines for both human and veterinary use. Eirgen Pharma also holds the production rights for numerous OSD products and has the capacity to manufacture each of these products at scale.

Taxonomy: Oral Solid Dose Drug Development, High Potency Medicines, CDMO Services, Pharmaceutical Manufacturing, Oncology Products, Veterinary Medicines, Global Market Supply, FDA and EMA Approval, High Containment Facility, Research and Development, Sterile Fill Finish, Microbiology Services, Global Supply Chain Management, Clinical Trial Materials, Immunosuppressant Molecules

Funding Rounds & Investors of Eirgen Pharma (0)

View All

There is no investment information

Latest News of Eirgen Pharma

View All

No recent news or press coverage available for Eirgen Pharma.

Similar Companies to Eirgen Pharma

View All
Aggrega Pharma, LLC - Similar company to Eirgen Pharma
Aggrega Pharma, LLC A trusted partner in the development and manufacture of niche generic finished dose products for the US Market.
Saudi Pharmaceutical Industries (SPI) - Similar company to Eirgen Pharma
Saudi Pharmaceutical Industries (SPI) Manufacturing Human and Veterinary Medicines. Established in 1994
Softigel®  - Similar company to Eirgen Pharma
Softigel® Making a difference with exceptional experiences for healthier lives. Innovation in softgel and related technologies.
Medfiles - Similar company to Eirgen Pharma
Medfiles R&D | Analytics | Clinical Trials | Regulatory Affairs | Pharmacovigilance – Medicines | MD & IVD | Food & Feed
Macter International Limited - Similar company to Eirgen Pharma
Macter International Limited Working Today For A Healthier Tomorrow